TY - JOUR
T1 - Treatment of Vasospastic Amaurosis Fugax with Calcium-Channel Blockers
AU - Winterkorn, Jacqueline
AU - Kupersmith, Mark J.
AU - Wirtschafter, Jonathan D.
AU - Forman, Scott
PY - 1993/8/5
Y1 - 1993/8/5
N2 - Amaurosis fugax, a brief loss of vision in one eye, is caused by hypoperfusion of the retinal circulation. If an attack of amaurosis is prolonged, the patient is at risk of permanent visual loss. Since the 1950s, amaurosis fugax has usually been attributed to embolism from the heart or great vessels1 or to carotid occlusive disease. Because of the difficulty in differentiating between these and other causes, amaurosis fugax remains a therapeutic challenge. Depending on the patency of the internal carotid arteries, the principal treatments are anticoagulation or antiplatelet therapy2 and carotid endarterectomy3. Vasospasm is rarely reported as a…
AB - Amaurosis fugax, a brief loss of vision in one eye, is caused by hypoperfusion of the retinal circulation. If an attack of amaurosis is prolonged, the patient is at risk of permanent visual loss. Since the 1950s, amaurosis fugax has usually been attributed to embolism from the heart or great vessels1 or to carotid occlusive disease. Because of the difficulty in differentiating between these and other causes, amaurosis fugax remains a therapeutic challenge. Depending on the patency of the internal carotid arteries, the principal treatments are anticoagulation or antiplatelet therapy2 and carotid endarterectomy3. Vasospasm is rarely reported as a…
UR - http://www.scopus.com/inward/record.url?scp=0027317055&partnerID=8YFLogxK
U2 - 10.1056/NEJM199308053290604
DO - 10.1056/NEJM199308053290604
M3 - Article
C2 - 8326973
AN - SCOPUS:0027317055
SN - 0028-4793
VL - 329
SP - 396
EP - 398
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 6
ER -